BridgeBio

Patent cliffs & loss of exclusivity

BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.

Company

AngelList URLhttps://angel.co/company/bridgebio
Business ModelCommerce
CAGE Code8FVJ9
Legal NameBridgeBio Pharma, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/bridgebio
Facebook URLhttps://www.facebook.com/BridgeBio-Pharma-100543364785856/
Full Address421 Kipling St, Palo Alto, California US

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. ATTRUBYACORAMIDIS HYDROCHLORIDESmall mol.Aug 2039

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

BridgeBio — patent cliffs & loss of exclusivity | CliffBio